Insulet Corporation Income Statement
PODD / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Insulet Corporation reported $2.7B in revenue and $247M in net income for FY2025. Revenue has grown at a 22.8% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.1B | $1.7B | $1.3B | $1.1B | $904.4M | $738.2M | $563.8M | $463.8M | $367.0M | $263.9M | $231.3M | $247.1M | $211.4M | $152.3M |
| Cost of Revenue | $768.2M | $625.9M | $537.2M | $499.7M | $346.7M | $322.1M | $257.9M | $193.6M | $186.6M | $155.9M | $130.6M | $104.2M | $134.7M | $119.0M | $85.5M |
| Gross Profit | $1.9B | $1.4B | $1.2B | $805.6M | $752.1M | $582.3M | $480.3M | $370.2M | $277.2M | $211.1M | $133.3M | $127.1M | $112.4M | $92.3M | $66.7M |
| SG&A Expense | $1.2B | $917.2M | $734.8M | $587.8M | $466.0M | $384.0M | $298.0M | $248.0M | $84.7M | $71.6M | $60.4M | $57.5M | $64.1M | $51.2M | $44.1M |
| R&D Expense | $301.1M | $219.6M | $205.0M | $180.2M | $160.1M | $146.8M | $132.3M | $94.8M | $75.7M | $55.7M | $43.2M | $27.9M | $21.8M | $24.4M | $21.9M |
| Operating Income | $473.8M | $308.9M | $220.1M | $37.6M | $126.0M | $51.5M | $50.0M | $27.4M | -$7.4M | -$10.7M | -$48.7M | -$8.9M | -$29.1M | -$36.0M | -$42.5M |
| Interest Expense | - | - | $36.2M | $36.0M | $61.7M | $48.1M | $34.6M | $28.9M | $21.2M | $14.4M | $12.7M | $14.6M | $16.9M | $16.4M | - |
| Income Tax | $92.4M | -$118.1M | $8.3M | $5.2M | $3.7M | $2.9M | $2.9M | $1.9M | $200.0K | $392.0K | $212.0K | $60.0K | $100.0K | $212.0K | -$11.2M |
| Net Income | $247.1M | $418.3M | $206.3M | $4.6M | $16.8M | $6.8M | $11.6M | $3.3M | -$26.8M | -$28.9M | -$73.5M | -$51.5M | -$45.0M | -$51.9M | -$45.8M |
| EPS (Basic) | $2.96 | $0.07 | $0.25 | $0.11 | $0.19 | $0.06 | -$0.46 | -$0.48 | - | - | - | - | - | - | - |
| EPS (Diluted) | $2.94 | $0.07 | $0.24 | $0.10 | $0.19 | $0.05 | -$0.46 | -$0.48 | -$0.17 | -$0.19 | -$0.83 | -$1.08 | -$0.98 | -$1.54 | -$2.43 |
| Shares Outstanding | 70.2M | 69.9M | 69.5M | 69.2M | 66.0M | 62.7M | 59.2M | 58.3M | 57.5M | 57.0M | 56.3M | 54.9M | 48.4M | 47.5M | - |
| Gross Margin | 71.6% | 69.8% | 68.3% | 61.7% | 68.5% | 64.4% | 65.1% | 65.7% | 59.8% | 57.5% | 50.5% | 55.0% | 45.5% | 43.7% | 43.8% |
| Operating Margin | 17.5% | 14.9% | 13.0% | 2.9% | 11.5% | 5.7% | 6.8% | 4.9% | -1.6% | -2.9% | -18.5% | -3.8% | -11.8% | -17.0% | -27.9% |
| Profit Margin | 9.1% | 20.2% | 12.2% | 0.4% | 1.5% | 0.8% | 1.6% | 0.6% | -5.8% | -7.9% | -27.9% | -22.3% | -18.2% | -24.5% | -30.1% |